Nalaganje...
Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges
Management of small cell lung cancer (SCLC) has not changed over the last decades. In more recent years, alterations of DNA repair machinery and other molecular pathways have been identified in SCLC and preclinical data suggest that dysregulation of these pathways might offer new therapeutic opportu...
Shranjeno v:
| izdano v: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683488/ https://ncbi.nlm.nih.gov/pubmed/31383005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0690-1 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|